19 September 2023 - Fundamental revision of the cost benefit assessment and addition of the concept of application-accompanying data collection. ...
14 September 2023 - Using weighted analyses across all patient subpopulations, atidarsagene autotemcel would achieve common thresholds for cost effectiveness if priced ...
14 September 2023 - The Department has today published version 4 of the agenda for the November 2023 PBAC meeting. ...
11 September 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...
6 September 2023 - The third version of the agenda for the next PBAC meeting is now available. ...
1 September 2023 - The initial agenda for the November 2023 PBAC meeting has been updated. ...
31 August 2023 - The agenda for this month's intracycle meeting has been updated. ...
28 August 2023 - The final report of the Efficient Funding of Chemotherapy Review is now available. ...
25 August 2023 - The agenda for the September 2023 PBAC intracycle meeting is now available. ...
25 August 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2023 PBAC ...
16 August 2023 - Another underwhelming agenda that was only published after agitation on social media. ...
16 August 2023 - For only the fifth time, the FDA recently threatened to fine a company or clinical trial ...
26 July 2023 - Registration now open for 3 August “Early Insights” webinar. ...
26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...
26 July 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...